 |
|
|
| |
Safety and Efficacy of Sofosbuvir/Velpatasvir with and without Ribavirin in Genotype 3 HCV-Infected Patients with Cirrhosis
|
| |
| |
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Maria Buti1, Juan A. Pineda2, Jose Luis Calleja3, Manuel Rodríguez4, Rosa Maria Morillas5, Juan Manuel Pascasio Acevedo6, Antonio Rivero7, Brian McNabb8, Gulan Zhang8, Gregory Camus8, Luisa M. Stamm8, Diana M. Brainard8, G. Mani Subramanian8, Jose A. Carrión9, Raul J. Andrade10, Luis Enrique Morano Amado11, Sabela Lens12, Juan Turnes Vazquez13, Marta Casado14, Rafael Esteban1
1Hospital Universitario Vall d'Hebron, Barcelona, Spain; 2Hospital Universitario Virgen de Valme, Sevilla, Spain; 3Hospital Universitario Puerta de Hierro, Majadahonda, Spain; 4Hospital Universitario Central de Asturias, Oviedo, Spain; 5Hospital Universitari Germans Trias i Pujol, Badalona, Spain; 6Hospital Universitario Virgen del Rocío, Sevilla, Spain; 7Hospital Universitario Reina Sofia, Cordoba, Spain; 8Gilead Sciences, Inc., Foster City, California, USA; 9Hospital del Mar, Barcelona, Spain; 10Hospital Universitario Virgen de la Victoria, Málaga, Spain; 11Hospital Alvaro Cunqueiro, Vigo, Spain; 12Hospital Clinic, University of Barcelona, Barcelona, Spain, CIBERhed; 13Complejo Hospitalario de Pontevedra, Pontevedra, Spain; 14Complejo Hospitalario Torrecárdenas, Almeria, Spain.
|
| |
|
|
|
|
|
